Sex steroid modulation of the serotonin behavioral syndrome.
The sex difference observed in frequency of rats exhibiting the serotonin behavioral syndrome induced by pargyline/1-tryptophan depends on hormonal state. Castration eliminated the sex difference in drug response in adult and prepubertal males, whereas ovariectomy had little effect. Dihydrotestosterone administration to males (10-30 days) reinstated the sex difference, but had little effect in females. Testicular feminized mutants (Tfm/y), deficient in androgen receptors, respond like females. Estrogen administration has no effect in either sex. Manipulation of the hormonal environment on postnatal days 0-7 (blockade of aromatization in males or estradiol administration to females) has no effect on the expression of the sex difference when the animals were tested as adults. Therefore, androgens acting via androgen receptors appear to mediate this subsensitivity of male rats to the drug challenge. The results of these experiments indicate that sex and hormonal environment are important variables in determining the experimental and perhaps clinical responses to drugs.
D000818:Animals; D002369:Castration; D013196:Dihydrotestosterone / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D012739:Gonadal Steroid Hormones / Q000502:physiology*; D006801:Humans; D008297:Male; D010293:Pargyline / Q000494:pharmacology; D011187:Posture; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000502:physiology*; D012727:Sex Characteristics; D012726:Sexual Behavior, Animal; D013239:Stereotyped Behavior / Q000187:drug effects*; D014364:Tryptophan / Q000494:pharmacology
D012739:Gonadal Steroid Hormones; D013196:Dihydrotestosterone; D012701:Serotonin; D004958:Estradiol; D014364:Tryptophan; D010293:Pargyline